[신한 리서치본부] 제약/바이오

📈 Analytical overview of Telegram channel [신한 리서치본부] 제약/바이오

Channel [신한 리서치본부] 제약/바이오 (@bio_shinhan) in the Korean language segment is an active participant. Currently, the community unites 21 288 subscribers, ranking 5 842 in the Economy & Finance category and 194 in the Korea region.

📊 Audience metrics and dynamics

Since its creation on невідомо, the project has demonstrated rapid growth, gathering an audience of 21 288 subscribers.

According to the latest data from 22 July, 2026, the channel demonstrates stable activity. Although there has been a change in the number of participants by 64 over the last 30 days and by -16 over the last 24 hours, overall reach remains high.

• Verification status: Not verified
• Engagement rate (ER): The average audience engagement rate is 51.81%. Within the first 24 hours after publication, content typically collects 32.80% reactions from the total number of subscribers.
• Post reach: On average, each post receives 11 031 views. Within the first day, a publication typically gains 6 984 views.
• Reactions and interaction: The audience actively supports content: the average number of reactions per post is 0.

📝 Description and content policy

The author describes the resource as a platform for expressing subjective opinions:
“안녕하세요. 신한투자증권 제약/바이오 담당 엄민용 연구위원, 이호철 수석연구원, 윤석현 연구원(RA), 임재현 연구원(RA) 입니다. 리서치본부 내 공표된 조사분석자료를 실시간으로 제공 할 수 있도록 정보 전달을 위해 운영되는 채널입니다.”

Thanks to the high frequency of updates (latest data received on 23 July, 2026), the channel maintains relevance and a high level of publication reach. Analytics show that the audience actively interacts with content, making it an important point of influence in the Economy & Finance category.